
T0124 Primary Human Hepatocytes, Metabolism Qualified, Plateable are pre-screened for confirmed CYP3A4/CYP1A2/CYP2C9/CYP2D6 baseline activity for human drug metabolism, DDI substrate inhibition, DILI screening, and pharmacokinetic prediction — without end-user lot qualification. Supplied by ABM as 5×105 cells/1.0 ml, frozen; BSL-2; RUO. MTA required.